Why Does Nature Make Having A Baby So Hard?

Our first story, Laura, has to do with yet another vaccine.

It does indeed.

And this is some really exciting news coming from Australia this week, where scientists have reported a major breakthrough in developing a personalised cancer vaccine.

So very different to a vaccine that we'd take for the flu, for example, a personalised cancer vaccine for melanoma, which is a really serious type of skin cancer.

So what's particularly interesting about this is mRNA technology, right? So funnily enough, we might know or remember what mRNA technology kind of is.

It's kind of familiar during this COVID-19 vaccine.

So the Moderna vaccine and the Pfizer vaccine use this technology.

But instead of this protecting us against a virus like COVID, it uses this technology to teach an immune system how to recognize and attack cancer cells.

So this study is a huge international clinical trial that was led from the Melanoma Institute Australia and University of Sydney.

And the results were kind of presented just this week at a major European cancer conference.

So this is a huge major milestone for personalised cancer vaccines with a really positive result of this clinical trial.

So it was a phase three clinical trial.

And what that means is a large scale study on a large number of patients and they test whether this new treatment acts better and is safer than current treatment that runs.

So

what exactly, because obviously, you know, Australia, obviously a lot of reason to be interested in melanoma, you know, they've constantly battled with skin cancer because of the location of the country and the culture of being outdoors all the time.

This is really, really intriguing.

What exactly did the study show? What did this vaccine actually do for those who were likely to get melanoma?

Yeah, exactly.

So the key thing here is that it doesn't necessarily, it's not like it would be given out to everyone to protect you from getting melanoma.

It's actually to treat patients who already have it.

So this study specifically looked at 1,100 patients across not just Australia, but 157 sites worldwide.

It was just led from Australia.

And these patients were patients who had undergone surgery to remove melanoma.

So they were the type of person that is likely to have melanoma again because they've had it before.

Exactly.

Our first story, Laura, has to do with yet another vaccine.

It does indeed.

And this is some really exciting news coming from Australia this week, where scientists have reported a major breakthrough in developing a personalised cancer vaccine.

So very different to a vaccine that we'd take for the flu, for example, a personalised cancer vaccine for melanoma, which is a really serious type of skin cancer.

So what's particularly interesting about this is mRNA technology, right? So funnily enough, we might know or remember what mRNA technology kind of is.

It's kind of familiar during this COVID-19 vaccine.

So the Moderna vaccine and the Pfizer vaccine use this technology.

But instead of this protecting us against a virus like COVID, it uses this technology to teach an immune system how to recognize and attack cancer cells.

So this study is a huge international clinical trial that was led from the Melanoma Institute Australia and University of Sydney.

And the results were kind of presented just this week at a major European cancer conference.

So this is a huge major milestone for personalised cancer vaccines with a really positive result of this clinical trial.

So it was a phase three clinical trial.

And what that means is a large scale study on a large number of patients and they test whether this new treatment acts better and is safer than current treatment that runs.

So

what exactly, because obviously, you know, Australia, obviously a lot of reason to be interested in melanoma, you know, they've constantly battled with skin cancer because of the location of the country and the culture of being outdoors all the time.

This is really, really intriguing.

What exactly did the study show? What did this vaccine actually do for those who were likely to get melanoma?

Yeah, exactly.

So the key thing here is that it doesn't necessarily, it's not like it would be given out to everyone to protect you from getting melanoma.

It's actually to treat patients who already have it.

So this study specifically looked at 1,100 patients across not just Australia, but 157 sites worldwide.

It was just led from Australia.

And these patients were patients who had undergone surgery to remove melanoma.

So they were the type of person that is likely to have melanoma again because they've had it before.

Exactly.